Generation Mechanism of Human Chemokine Gene Family
人类趋化因子基因家族的产生机制
基本信息
- 批准号:09670135
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Chemokine family is a group of cytokines involved in inflammation, virus infection and cell growth. There are now well over 40 chemokines including those cloned by our group. We found several ESTs encoding novel chemokines in the EST database and cloned the cDNAs encoding CC chemokines termed LARC (liver and activation-regulated chemokine), SLC (secondary lymphoid tissue chemokine), ELC (EBI 1-ligand chemokine), PARC (pulmonary and activation-regulated chemokine), LEC (liver-expressed chemokine) and CX3C chemokine fractalkine. We determined their gene loci. From these results, it is apparent that the genes for the CC chemokines which mainly attract monocytes cluster on Chr 17, whereas the genes for the CC chemokines which are mainly chemotactic for lymphocytes reside on the other chromosomes. We also characterized the PARC gene in the Chr 17 chemokine cluster, and found that the gene had been generated by fusion of two MIP-1alpha-like sequences. In addition, there is no mouse counterpart of the human PARC gene. This indicates that the PARC gene was generated after humans and rodents had diverged. These results suggest that CC chemokine genes were generated on Chr 17 by successive duplication events of the region containing the MIP-lalpha gene. Hence, the CC chemokines located on other than Chr 17 had emerged before most of the CC chemokines on Chr 17 were generated, and the genes recently generated by duplication such as the PARC gene are located in the large chemokine cluster on Chr 17.
趋化因子家族是一组参与炎症、病毒感染和细胞生长的细胞因子。现在有超过40种趋化因子,包括我们小组克隆的那些。我们在EST数据库中发现了几个编码新趋化因子的EST,并克隆了编码CC趋化因子的cDNA,这些趋化因子被称为LARC(肝脏和活化调节趋化因子)、SLC(次级淋巴组织趋化因子)、ELC(EBI 1-配体趋化因子)、PARC(肺和活化调节趋化因子)、LEC(肝脏表达趋化因子)和CX 3C趋化因子fractalkine。我们确定了他们的基因位点。从这些结果可以看出,主要吸引单核细胞的CC趋化因子的基因聚集在Chr 17上,而主要对淋巴细胞具有趋化性的CC趋化因子的基因位于其他染色体上。我们还鉴定了PARC基因在Chr 17趋化因子簇中的特征,并发现该基因是由两个MIP-1 α样序列融合产生的。此外,没有人类PARC基因的小鼠对应物。这表明PARC基因是在人类和啮齿动物分化后产生的。这些结果表明,CC趋化因子基因产生的Chr 17的连续重复事件的区域含有MIP-1 α基因。因此,位于Chr 17以外的CC趋化因子在Chr 17上的大多数CC趋化因子产生之前已经出现,并且最近通过复制产生的基因如PARC基因位于Chr 17上的大趋化因子簇中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M. Nagira et al.: "Molecular cloning of a novel human CC chemokine Secondary Lymphoid-tissue Chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13" J. Biol. Chem.272(31). 19518-19524 (1997)
M. Nagira 等人:“新型人类 CC 趋化因子次级淋巴组织趋化因子的分子克隆,它是淋巴细胞的有效趋化因子,并定位到染色体 9p13”,J. Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomiyama, H., Amano, K., Kusuda, J., Imai, T., Miura, R., Yoshie, O.and Matsuda, Y.: "The human CC chemokine TECK (SCYA25) maps to chromosome 19p13.2" Genomics. 51 (2). 311-312 (1998)
Nomiyama, H.、Amano, K.、Kusuda, J.、Imai, T.、Miura, R.、Yoshie, O. 和 Matsuda, Y.:“人类 CC 趋化因子 TECK (SCYA25) 映射到染色体 19p13.2
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nagira, M., Imai, T., Yoshida, R., Takagi, S., Iwasaki, M., Baba, M., Tabira, Y., Akagi, J., Nomiyama, H., and Yoshie, O.: "A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells an
Nagira, M.、Imai, T.、Yoshida, R.、Takagi, S.、Iwasaki, M.、Baba, M.、Tabira, Y.、Akagi, J.、Nomiyama, H. 和 Yoshie, O.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Van Coillie, E., Fiten, P., Nomiyama, H., Sakaki, Y., Miura, R., Yoshie, O., Van Damme, J.and Opdenakker, G.: "The human MCP-2 gene (SCYA8) : cloning, sequence analysis, tissue-expression and assignment to the C-C chemokine gene contig on chromosome 17q11
Van Coillie, E.、Fiten, P.、Nomiyama, H.、Sakaki, Y.、Miura, R.、Yoshie, O.、Van Damme, J. 和 Opdenakker, G.:“人类 MCP-2 基因(
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
R. Yoshida et al.: "EBI-ligand chemokine(ELC)attracts a broad spectrum of lymphocytes: Activated T cells strongly upregulate CCR7 and efficiently migrate toward ELC" Int. Immunol.10(7). 901-910 (1998)
R. Yoshida 等人:“EBI 配体趋化因子 (ELC) 吸引广谱淋巴细胞:激活的 T 细胞强烈上调 CCR7 并有效地向 ELC 迁移”Int.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOMIYAMA Hisayuki其他文献
NOMIYAMA Hisayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOMIYAMA Hisayuki', 18)}}的其他基金
Cellular protein quality control mechanism and the evolution of chemokine CXCL1L gene
细胞蛋白质量控制机制及趋化因子CXCL1L基因的进化
- 批准号:
23570275 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Birth and Death of Chemokine Family Genes and Gain of Novel Functions
趋化因子家族基因的诞生和死亡以及新功能的获得
- 批准号:
19510197 - 财政年份:2007
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analyses of a seven transmembrane receptor essential for osteoclast differentiation
破骨细胞分化必需的七次跨膜受体的功能分析
- 批准号:
17590253 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Biological Study of Species-specific Chemokines
物种特异性趋化因子的分子生物学研究
- 批准号:
13670125 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Biological Study of Chemokine Gene Family
趋化因子基因家族的分子生物学研究
- 批准号:
11670130 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Negative transcriptional regulatory mechanisms of cytokine LD78 which regulates hematopoiesis
造血细胞因子LD78的负转录调控机制
- 批准号:
06670149 - 财政年份:1994
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
乙肝病毒感染对LARC表达的影响及其免疫学意义
- 批准号:39870009
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
Safety net or double-edged sword? Long-acting reversible contraception (LARC) use and STBBI risk in young Canadians
安全网还是双刃剑?
- 批准号:
489130 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Operating Grants
Exploring the uptake and provision of Long Acting Reversible Contraception (LARC) among 'vulnerable' groups: a mixed-methods study
探索“弱势”群体对长效可逆避孕药 (LARC) 的接受和提供:一项混合方法研究
- 批准号:
2739637 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Studentship
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.
避孕临床试验网络,对 LARC 方法进行临床评估以确定比较有效性、可接受性和安全性。
- 批准号:
10788175 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.
避孕临床试验网络,对 LARC 方法进行临床评估以确定比较有效性、可接受性和安全性。
- 批准号:
10412886 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.
避孕临床试验网络,对 LARC 方法进行临床评估以确定比较有效性、可接受性和安全性。
- 批准号:
10551058 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
Live cell affinity receptor chromatography (LARC)
活细胞亲和受体层析 (LARC)
- 批准号:
298426-2009 - 财政年份:2013
- 资助金额:
$ 1.98万 - 项目类别:
Discovery Grants Program - Individual
Live cell affinity receptor chromatography (LARC)
活细胞亲和受体层析 (LARC)
- 批准号:
298426-2009 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
Discovery Grants Program - Individual
meta-network Learning And Research Center Meta-LARC
元网络学习与研究中心Meta-LARC
- 批准号:
8415605 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
meta-network Learning And Research Center Meta-LARC
元网络学习与研究中心Meta-LARC
- 批准号:
8917146 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:














{{item.name}}会员




